DHR completes CEO search for Harvard Bioscience Inc.
Sep 15, 2013
Holliston, Mass. (September 15, 2013) - Global executive search firm DHR International is pleased to announce the placement of Jeffrey A. Duchemin as chief executive officer for Harvard Bioscience Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine. Managing Director, Boston and Executive Vice President Diane Coletti and John Spencer, executive vice president,- San Francisco, completed the search.
Earl Lewis, chairman of Harvard Bioscience's Board of Directors, commented, "Mr. Duchemin is a proven global executive with extensive experience in the fields of life science research, diagnostic and medical devices. The Board of Directors is excited to have Jeff join Harvard Bioscience and is looking forward to working with him to bring further success to the Company."
Prior to joining Harvard Bioscience, Duchemin spent 16 years with Becton Dickinson across the company’s three business segments; BD Medical Systems, BD Diagnostic Systems, and BD Biosciences. In October 2012 BD Biosciences, Discovery Labware was acquired by Corning Life Sciences and Duchemin became the Global Business Head for Corning Life Sciences.
Duchemin earned an M.B.A. from Southern New Hampshire University and a B.S. in Accounting from the University of Massachusetts Dartmouth.
About Harvard Bioscience
Harvard Bioscience ("HBIO") is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments, used to advance life science research and regenerative medicine. Our products are sold to thousands of researchers in over 100 countries primarily through our 850 page catalog (and various other specialty catalogs), our website, through distributors, including GE Healthcare, Thermo Fisher Scientific and VWR, and via our field sales organization. HBIO has sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden and Spain with additional facilities in France and Canada. Visit harvardbioscience.com.